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Background:  Acute  lower  respiratory  tract  infections  (ALRI)  commonly  result  in fatal  outcomes  in  the
young  children  of  Papua  New  Guinea  (PNG).  However,  comprehensive  studies  of  the  viral  aetiology  of
ALRI  have  not  been  conducted  in PNG  for  almost  30 years.
Objectives: To  determine  the viruses  associated  with  ALRI  among  children  living in the  PNG  highlands
using  sensitive  molecular  detection  techniques.
Study design:  Pernasal  swabs  were  collected  routinely  between  1 week  and  18  months  of  age  and  also
during  episodes  of  ALRI,  as  part  of  a  neonatal  pneumococcal  conjugate  vaccine  trial.  A  tandem  multiplex
real-time  PCR  assay  was used  to  test  for a comprehensive  range  of  respiratory  viruses  in samples  collected
from  221  young  children.  Picornavirus  typing  was  supported  by DNA  sequence  analysis.
Results: Recognized  pathogenic  respiratory  viruses  were  detected  in  198/273  (73%)  samples  collected
from  children  with  no  evidence  of  ALRI  and  69/80  (86%)  samples  collected  during  ALRI episodes.  Human
rhinoviruses  (HRV)  species  A, B and  C were  detected  in  152  (56%)  samples  from non-ALRI  children  and  50
(63%)  samples  collected  during  ALRI  episodes.  Partial  structural  region  sequences  for  two  new  species  C
rhinoviruses  were  added  to the  GenBank  database.  ALRI  was  associated  with  detection  of  adenovirus
species  B (p  < 0.01)  or C (p <  0.05),  inﬂuenza  A (p  <  0.0001)  or respiratory  syncytial  virus  (p < 0.0001).
Multiple  viruses  were  detected  more  often  during  ALRI  episodes  (49%)  than  when  children  displayed
no  symptoms  of  ALRI  (18%)  (p <  0.0001).
Conclusions:  The  burden  of  infection  with  respiratory  viruses  remains  signiﬁcant  in young  children  living
in  the  PNG  highlands.
CrowAbbreviations: PNG, Papua New Guinea; ALRI, acute lower respiratory tract
nfection;  HRV, human rhinovirus; HEV, human enterovirus; PCV, pneumococ-
al  conjugate vaccine; STGGB, skim milk-tryptone-glucose-glycerin-broth; HAdV,
uman adenovirus; HBoV, human bocavirus; HCoV, human coronavirus; PIV, parain-
uenza virus; PyV, polyomavirus; RSV, respiratory syncytial virus; MS2, MS2  RNA
oliphage; EHV, equine herpesvirus; HMPV, human metapneumovirus; URTI, upper
espiratory tract infection; UTR, untranslated region.
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1. Background
Acute lower respiratory infections (ALRI) are the leading cause of
death in children, accounting for approximately two  million deaths
worldwide annually.1 Currently there is limited information on the
role of many of the respiratory viruses in lower respiratory tract
infections in children. This is particularly true in developing coun-
tries where this knowledge is critically important in improving
the management and prevention of childhood respiratory infec-
tions. Children in the highlands of Papua New Guinea (PNG) suffer
an average of 4.3 ALRIs by the age of 18 months.2 Previous stud-
Open access under CC BY license.ies of respiratory viral infection in young children in PNG relied
on the detection of viral antigens by immunoﬂuorescence and
traditional cell culture techniques.3,4 Compared with nucleic acid
detection tests, such techniques lack sensitivity for the detection
nse.
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Fig. 1. The detection (%) of adenovirus type B or C, inﬂuenza virus A and respira-36 G.R.  Chidlow et al. / Journal of 
f many respiratory viruses, particularly the recently described
uman coronaviruses, respiratory polyomaviruses, bocavirus and
hinovirus C.5–10 Furthermore, since a number of these viruses
ave been detected commonly in the respiratory tract of asymp-
omatic children in developed countries, their pathogenicity is
ncertain.11–15
. Objectives
We  undertook a PCR-based study to identify and characterize
espiratory viruses associated with ALRI in young PNG children.
.  Study design
A  randomized trial of neonatal 7-valent pneumococcal conju-
ate vaccine (PCV) was conducted in the Asaro Valley, Eastern
ighlands Province, PNG between May  2005 and March 2009.16 As
art of this trial, pernasal swabs (rayon-tipped, metal shaft swabs)
ere collected routinely at 1, 2, 3, 4 weeks and 3, 9 and 18 months
f age, and also when children presented with symptoms of ALRI.
LRI was deﬁned as cough with raised respiratory rate (≥60/min at
ge <1 month, ≥50/min at age 1 to <12 months and ≥40/min at age
12 months) in accordance with local recommendations17 based
n World Health Organization criteria.18 During the course of the
accine trial, 1888 pernasal swabs were collected from 319 young
hildren. Swabs were collected into 1 mL  of skim milk-tryptone-
lucose-glycerin-broth (STGGB)19 and stored at −80 ◦C. A limited
umber of those samples collected between January 2006 and
ugust 2008 were shipped to Perth, Western Australia for viral
tudies. Those samples included 80 from young children with ALRI
nd 273 from children with no evidence of ALRI. Multiple sam-
les from separate presentations were included from 95 of the 221
oung children represented in the study. ALRI and non-ALRI sam-
les were matched for gender, PCV group, age, season of birth and
ollection date. It was not possible to identify an asymptomatic
ontrol group due to the high prevalence of upper respiratory tract
ymptoms such as rhinorrhoea in this population.2
Nucleic acid was extracted from a 200 L volume of clinical
ample20,21 and tested for a comprehensive range of respiratory
iruses using a tandem multiplex real-time PCR assay20 that detects
uman adenovirus (HAdV) species B-D; human bocavirus (HBoV);
oronaviruses (HCoV) OC43, 229E, HKU1 and NL63; inﬂuenza
iruses A, B and C; parainﬂuenzaviruses (PIV) 1–4; KI and WU  poly-
maviruses (PyV); respiratory syncytial virus (RSV) types A and
; and the MS2  RNA coliphage (MS2) and equine herpes virus 4
EHV) added to the sample lysis buffer as extraction, ampliﬁca-
ion and inhibition controls.22,23 Negative controls were included
etween every 5 clinical samples and treated as samples for the
ompletion of the assays. Additional PCR assays were directed at
he matrix gene of human metapneumovirus (HMPV) and the 5′UTR
f picornaviruses,24–26 and products conﬁrmed by sequence anal-
sis. Further genetic characterization of rhinovirus (HRV) species
tilized PCR primers directed at the VP1 and VP4/2 regions of the
enome.27–29
.1. Statistical analyses
Data  were analyzed using the Yates-corrected Chi-square test
nd p-values <0.05 were considered statistically signiﬁcant.
.  ResultsPernasal swabs (n = 80) were collected from children with
n ALRI of 0–24 days’ duration at time of sample collection
median = 3.0 days). A further 273 samples were collected fromtory  syncytial virus in children grouped by age (months) with no ALRI symptoms 
(n = 273) and during ALRI episodes  (n = 80). Signiﬁcant associations with disease
are  marked *p < 0.05, **p < 0.005, ***p < 0.0005.
children with no ALRI symptoms at the time of specimen collection
or within one week of that sample collection. These yielded
an extensive range of respiratory viruses (Table 1). Adenovirus
(p < 0.01), inﬂuenza A (p < 0.0001) and RSV (p < 0.0001) were
associated with ALRI, but signiﬁcant adenovirus associations were
conﬁned to species B (p < 0.01) and C (p < 0.05). When analyzed by
age (Fig. 1), the association between RSV and ALRI was signiﬁcant
in 2- to <12-month-age groups (p < 0.0005–0.005), adenovirus B or
C and ALRI (p < 0.05) in the 6–18 month age groups and inﬂuenza
A and ALRI (p < 0.005) in the 6- to <12-month-age group.
There was no evidence of an ALRI disease association for
bocavirus or the KI and WU polyomaviruses, which were detected
in 53 (19%), 4 (1.5%) and 75 (28%) of non-ALRI samples and 18
(22.5%), 0 and 16 (20%) samples from children during episodes of
ALRI, respectively.
Picornaviruses were detected in 61.5% of samples, mainly HRV
species A and C based on 5′UTR sequencing (Fig. 2), including 13
mixed picornavirus infections. Adequate capsid gene sequences
were obtained for 150 of the samples: 146 partial VP4/VP2
sequences and 76 partial VP1 sequences. These matched the 5′UTR
results for 67 samples with HRV-A, 9 with HRV-B, 48 with HRV-C,
11 with HEV and 13 with mixed picornavirus species. One picor-
navirus was unable to be assigned to a species as the 5′UTR matched
best with HRV-B, the VP1 sequence with HRV-A and the VP2/4 with
HEV. Limited sample volume and lack of virus isolates prevented
further sequence analysis of these samples. There was no associa-
tion of picornavirus detection with ALRI when analyzed overall or
by individual species (Fig. 2).
Two new species C rhinoviruses were detected from non-
ALRI patients and designated as HRV-C47 and HRV-C48 by the
Picornaviridae Study Group (http://www.picornastudygroup.com/
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Table 1
Viruses detected in pernasal swabs from young children in PNG with and without clinical symptoms of acute lower respiratory tract infection (ALRI).
Virus detected non-ALRI (n = 273) ALRI (n = 80) p Value
No  detections (%) No detections (%)
Any virus 223 (82) 72 (90) 0.111
Any  recognized pathogenic virusa 198 (73) 69 (86) 0.018
Adenovirus  B–D 18 (6.6) 14 (17.5) 0.006
Adenovirus  B 7 (2.6) 8 (10.0) 0.010
Adenovirus  C 3 (1.1) 5 (6.2) 0.022
Adenovirus  D 9 (3.3) 1 (1.2) 0.557
Bocavirus  53 (19.4) 18 (22.5) 0.655
Coronavirus 31 (11.4) 11 (13.8) 0.700
Coronavirus-229E 2 (0.7) 0 (0.0) –
Coronavirus-HKU1 6  (2.2) 3 (3.8) 0.710
Coronavirus-NL63 18 (6.6) 3 (3.8) 0.498
Coronavirus-OC43 5 (1.8) 5 (6.2) 0.087
Enterovirus  20 (7.3) 1 (1.2) 0.080
Human  metapneumovirus 1 (0.4) 3 (3.8) 0.056
Inﬂuenza  A virus 4  (1.5) 10 (12.5) <0.0001
Inﬂuenza  B virus 1 (0.4) 2 (2.5) 0.256
Inﬂuenza  C virus 1 (0.4) 0 (0.0) –
Parainﬂuenza virus 1–4 14 (5.1) 8 (10.0) 0.186
Rhinovirus  (HRV) 152  (55.7) 50 (62.5) 0.369
HRV-A  70 (25.6) 27 (33.8) 0.198
HRV-B  16 (5.9) 2 (2.5) 0.361
HRV-C  56 (20.5) 18 (22.5) 0.820
Respiratory  syncytial virus (RSV) 10 (3.7) 18 (22.5) <0.0001
RSV  A 8 (2.9) 14 (17.5) <0.0001
RSV  B 2 (0.7) 6 (7.5) 0.002
KI  polyoma virus 4  (1.5) 0 (0.0) 0.612
WU  polyoma virus 75 (28.2) 16 (20.0) 0.189
N
p
a aviru
t
s
J
m
w
l
t
d
w
a
a
t
w
o
o
a
A
F
Humber (%) samples in which particular virus was detected.
 Value: Chi-square with Yates’correction (in bold font when signiﬁcant).
Any recognized pathogenic respiratory virus does not include bocavirus or polyom
ypes/enterovirus/hrv-c.htm).  VP1 and VP4/2 coding region
equences were deposited in GenBank under accession numbers
F519760–JF519763.
Sequential samples separated by 0.5–13 months (mean = 4.9
onths), were available for 95 children. For one child, HCoV-OC43
as detected in consecutive samples separated by 17 weeks. The
ater sample was collected when the child had an ALRI and also con-
ained HRV-A and RSV-B. A further 41 children had rhinoviruses
etected in consecutive samples. However, except for one child
ith HRV-A12 detected in two samples collected 3 months apart,
ll had different HRV types in the different samples.
Multiple viruses were detected in 53/80 (66.2%) ALRI samples
nd 115/273 (42.2%) non-ALRI samples (p = 0.0002). Combinations
hat only included viruses shown to be individually pathogenic
ere detected in 39/80 (48.8%) of ALRI samples and 50/273 (18.3%)
f non-ALRI samples (p < 0.0001). In contrast, combinations that
nly contained HBoV, PyV, HRV, HEV or adenovirus D showed no
ssociation with ALRI. The viruses signiﬁcantly associated with
LRI, namely RSV, inﬂuenza A, adenovirus B and adenovirus C,
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ig. 2. Picornaviruses detected (%) in samples collected from young children in the absen
EV,  human enterovirus.ses.
were  detected as mixed infections with any other virus in 19/273
(7.0%) of the non-ALRI cases and 29/80 (36.3%) of the ALRI samples
(p < 0.0001).
5. Discussion
Inﬂuenza A, RSV, adenovirus B and adenovirus C were all
common and signiﬁcant contributors to ALRI in children in PNG.
In contrast, the rhinoviruses, bocavirus and respiratory poly-
omaviruses were not associated with ALRI. For the other pathogens
the numbers were too low to draw any conclusions. Mixed infec-
tions were also more likely to be associated with ALRI than were
single infections, and this effect was  strongest when it was a com-
bination of two  viruses that individually also showed a signiﬁcant
association with ALRI.Although  only a few sequential samples from individual chil-
dren were investigated, the same virus was detected from the same
child on only two occasions. Conversely, numerous unique rhi-
noviruses were detected in sequential samples from 41 children.
V-C HEV Multiple
Picornaviruses
Untyped
ce of ALRI  (n = 273) and during ALRI episodes  (n = 80). HRV, human rhinovirus;
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his suggests that the children of PNG are infected with a variety of
ifferent respiratory viruses rather than chronic colonization with
 particular viral species.
The  high rate of respiratory virus detection (>80% of all partici-
ants) and the frequent multiple carriage (66% of ALRI and 42% of
on-ALRI children) exceeds the detection rates of the most recent
tudy in this setting, conducted almost 30 years ago. In that study
irus detection rates of 65% and 43% in nasopharyngeal secre-
ions of children with or without ALRI respectively, were reported
ith mixed infections in 37% of both healthy and sick children.4
owever, fewer viruses were sought (measles, adenovirus, RSV,
nﬂuenza viruses A and B, parainﬂuenza types 1 and 3) and cell
ulture or viral antigens were used for detection. Other studies
f ALRI using traditional diagnostic methods have also found low
ates in Gambian infants (49% of pneumonia cases and in 19% of the
ontrols),30 and Nigerian children (50% of pneumonia cases, with
ultiple viral pathogens detected in 16%).31
Studies using PCR in children with symptomatic respiratory dis-
ase detect viruses in 44–92% of patients depending on the cohort
ize and the range of respiratory agents investigated, and multi-
le viruses in 2–20% of samples.29,32–37 A case–control study of
epalese children aged 2–35 months, reported virus detection rate
f 36.5% in pneumonia cases and 7.1% in controls, but excluded
hinoviruses, adenoviruses or coronaviruses.38 In rural Kenya res-
iratory viruses were detected in 56% of children hospitalized with
evere pneumonia, 44% with mild upper respiratory tract infections
URTI) and 28% of controls, but did not include picornaviruses.39
n the same study multiple viruses were detected in 9.7% of sam-
les from children with pneumonia, 6.2% from those with URTI and
.8% from controls. They found that only RSV, either alone or in
ombination with other viruses, was signiﬁcantly associated with
ither URTI or pneumonia, unlike our study which also found sig-
iﬁcant associations of inﬂuenza A, ADV-B and ADV-C with ALRI.
he differences may  reﬂect the lower incidence of these viruses
n their population, being 5.8% and 3.8% compared with 12.5% and
7.5% respectively for inﬂuenza A and adenoviruses in our study.
urthermore, as they did not speciate their adenoviruses and as
e found that only some ADV species were signiﬁcantly associated
ith ALRI, it is possible that differences in species distributions may
ave affected the observed disease association.
Our assay detected some viruses (HBoV, KIPyV and WUPyV)
hat have uncertain roles as respiratory tract pathogens. We  found
o association between these viruses and ALRI in this study. Even
ith exclusion of these viruses, detection rates of potential viral
athogens remained high (86% in children with ALRI and 73% in
on-ALRI children), and multiple virus detection rates were 49%
or ALRI and 18% for non-ALRI.
The  anticipated association of rhinoviruses with ALRI in this
opulation40–42 was not supported when analyzed either as a group
r as individual species. Similarly, other viruses detected were not
hown to be associated with ALRI. Only RSV, inﬂuenza A, aden-
virus B and adenovirus C were signiﬁcantly associated with ALRI
nd were detected as mixed infections with any other virus in 7.0%
f the non-ALRI cases and 36.3% of the ALRI samples. Since these
esults are consistent with previous studies using traditional detec-
ion methods, this suggests that the newer nucleic acid detection
ethods do not detect additional signiﬁcant respiratory pathogens,
t least for lower respiratory tract disease. This emphasizes the
mportance of both accurate characterization and speciation of the
iruses, and the inclusion of control populations. There are also data
o indicate that measuring viral loads, although technically difﬁcult,
ay assist in assigning signiﬁcance.43A limitation of this study was that we could not exclude
hildren with an upper respiratory tract infection (URTI) since
asal discharge is almost universal in this population.2 Therefore,
hile many of the viruses detected in this study did not show anyl Virology 54 (2012) 235– 239
association  with ALRI, we  could not determine whether they may
have contributed to URTI. We  also recognize that pernasal swabs
will miss some lower respiratory tract viral infections, but it would
have been both impractical and unethical to obtain bronchial
lavage samples from this population.
In the current study, the picornavirus PCR targeted the rela-
tively conserved 5′UTR region of the genome and tentative species
and group typing was made using sequence information from that
region. As there has been controversy regarding the reliability of
rhinovirus speciation using 5′UTR sequences rather than structural
gene regions,44,45 we  also attempted sequencing of VP1 and VP4
capsid genes. Partial sequence was  obtained for 150/217 samples
and, while assignment of particular types requires structural gene
sequence information, the discrimination between HRV A, B and C
species correlated well with the 5′UTR results.
Two new picornavirus types, HRV-C47 and HRV-C48, were
detected in single patients without ALRI but disease associations
could not be assessed.
6.  Conclusions
There is a high burden of infection with respiratory viruses in
the children of the PNG highlands, with mixed infections common,
particularly in children with ALRI. The association between ALRI
and the detection of adenoviruses, inﬂuenza A virus or RSV, sug-
gests that these viruses have a signiﬁcant health impact. This is
important in informing decisions about the value of inﬂuenza vac-
cination in children and emphasizing the importance of infection
control measures to prevent spread of these viruses within health
care and community settings.
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